Outcomes of allogeneic HCT in patients with Hodgkin lymphoma in the era of checkpoint inhibitors: A joint CIBMTR and EBMT analysis Meeting Abstract
| Authors: | Perales, M. A.; Awan, F.; Boumendil, A.; Chen, S.; Bazarbachi, A.; Finel, H.; Glass, B.; Herrera, A. F.; Kharfan-Dabaja, M.; Martinez, C.; Montoto, S.; Sauter, C.; Ahn, K. W.; Hamadani, M.; Sureda, A. M. |
| Abstract Title: | Outcomes of allogeneic HCT in patients with Hodgkin lymphoma in the era of checkpoint inhibitors: A joint CIBMTR and EBMT analysis |
| Meeting Title: | 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) |
| Journal Title: | Bone Marrow Transplantation |
| Volume: | 57 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Mar 19-23 |
| Meeting Location: | Virtual |
| ISSN: | 0268-3369 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2022-11-02 |
| Start Page: | 11 |
| End Page: | 12 |
| Language: | English |
| ACCESSION: | WOS:000878153300020 |
| PROVIDER: | wos |
| PUBMED: | 36323938 |
| DOI: | 10.1038/s41409-022-01814-3 |
| Notes: | Meeting Abstract: O002 -- located in section, "Physicians Award Winners (O001-O007)" -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
